ESC Premium Access

Long-term outcomes

Topic: Epidemiology, Prognosis, Outcome
Sponsored by Thrombosis Research Institute

Congress Presentation

About the speaker

Professor Dan Atar

Oslo University Hospital Rikshospitalet, Oslo (Norway)
16 presentations
0 follower

6 more presentations in this session

What have registries taught us? New insights from GARFIELD-AF

Speaker: Professor A. Kakkar (London, GB)

Thumbnail

Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding

Speaker: Professor K. Fox (Edinburgh, GB)

Thumbnail

Changes in antithrombotic therapy after atrial fibrillation diagnosis

Speaker: Doctor F. Cools (Brasschaat, BE)

Thumbnail

Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions

Speaker: Professor J. Camm (London, GB)

Thumbnail

Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study

Speaker: Professor S. Goto (Isehara, JP)

Thumbnail

Access the full session

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

Speakers: Professor D. Atar, Professor A. Kakkar, Professor K. Fox, Doctor F. Cools, Professor J. Camm...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb